Pepg stockholders with large losses are encouraged to contact robbins llp for information about the securities class action lawsuit against pepgen inc.

San diego, june 27, 2025 (globe newswire) -- robbins llp reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired pepgen inc. (nasdaq:pepg) securities between march 7, 2024 and march 3, 2025. pepgen is a clinical-stage biotechnology company that focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases.
PEPG Ratings Summary
PEPG Quant Ranking